Cost-Effectiveness Analysis of Rotavirus Vaccination for Children in Korea
2 other identifiers
observational
200
1 country
3
Brief Summary
The primary objective of the proposed project is to estimate the economic impact of a national rotavirus immunization program in preventing rotavirus diarrhea among Korean children.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2008
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 29, 2008
CompletedFirst Posted
Study publicly available on registry
May 1, 2008
CompletedStudy Start
First participant enrolled
May 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2009
CompletedFebruary 19, 2009
February 1, 2009
1.1 years
April 29, 2008
February 18, 2009
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
patients' cost
one year
Study Arms (3)
1
patients visited to Severance hospital
2
patients visited to Youngdong Severance hospital
3
patients visited to Wonju Christian hospital
Eligibility Criteria
patients to visit assigned hospital
You may qualify if:
- children aged under 5 years and diagnosed as acute gastroenteritis
You may not qualify if:
- none
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Yonsei Universitylead
- Merck Sharp & Dohme LLCcollaborator
- Severance Hospitalcollaborator
Study Sites (3)
Wonju Christian Hospital
Wŏnju, Gangwon-do, South Korea
Yonsei University Health System Severance Hospital
Seoul, 120-752, South Korea
Youngdong Severance Hospital
Seoul, South Korea
Related Publications (3)
Hong SK, Lee SG, Lee SA, Kang JH, Lee JH, Kim JH, Kim DS, Kim HM, Jang YT, Ma SH, Kim SY, Paik SY. Characterization of a G11,P[4] strain of human rotavirus isolated in South Korea. J Clin Microbiol. 2007 Nov;45(11):3759-61. doi: 10.1128/JCM.01505-07. Epub 2007 Aug 29.
PMID: 17728473BACKGROUNDKim DS, Lee TJ, Kang JH, Kim JH, Lee JH, Ma SH, Kim SY, Kim HM, Shin SM. Immunogenicity and safety of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine in healthy infants in Korea. Pediatr Infect Dis J. 2008 Feb;27(2):177-8. doi: 10.1097/INF.0b013e31815aba79.
PMID: 18174862BACKGROUNDLu CY, Lauderdale TL, Fang YH, Wang CY, Ho YH, Hung CL, Chang LY, Lee CY, Huang LM. Disease burden and related medical costs of rotavirus infections in Taiwan. BMC Infect Dis. 2006 Dec 15;6:176. doi: 10.1186/1471-2334-6-176.
PMID: 17173677BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dong Soo Kim, MD, PhD
professor
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
April 29, 2008
First Posted
May 1, 2008
Study Start
May 1, 2008
Primary Completion
June 1, 2009
Study Completion
June 1, 2009
Last Updated
February 19, 2009
Record last verified: 2009-02